IMCC
IM Cannabis Corp.
There isn't enough reported data to score IMCC yet.
IMCC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
IMCC's revenue, profitability, cash flow and balance sheet are all currently weak.
IMCC PE Valuation
IMCC has no meaningful PE right now: it lost money over the past year.
IMCC Forward outlook
There aren't enough analyst estimates for IMCC to show an outlook.
IMCC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2020 | -$629.57 | -$607.83 |
IMCC lost $629.57 per share over the past year, a bigger loss than the year before.
IMCC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.3M | -40% |
| Q1 2026 | $6.1M | -31% |
| Q4 2025 | $7.9M | -16% |
| Q3 2025 | $9.7M | -0.2% |
| Q2 2025 | $8.9M | -14% |
| Q1 2025 | $8.8M | +3.6% |
| Q4 2024 | $9.4M | +25% |
| Q3 2024 | $9.8M | +12% |
IMCC's revenue has slid since its 2024 peak: $5M last quarter, down 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -25 points |
| Q1 2026 | -19% | -21 points |
| Q4 2025 | -25% | +123 points |
| Q3 2025 | -30% | -37 points |
| Q2 2025 | -2.8% | -22 points |
| Q1 2025 | 1.3% | +48 points |
| Q4 2024 | -148% | -99 points |
| Q3 2024 | 6.9% | -11 points |
IMCC's operating margin was −28% last quarter, down 25 points from the same quarter a year ago.
IMCC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$927.5K | -$610.6K |
| Q1 2026 | -$134.3K | -104% |
| Q4 2025 | $1.9M | +$4.8M |
| Q3 2025 | -$2.5M | -231% |
| Q2 2025 | -$317K | -234% |
| Q1 2025 | $3.1M | +$3.6M |
| Q4 2024 | -$3M | -$2.8M |
| Q3 2024 | $1.9M | -50% |
IMCC has burned cash in most quarters: −$2M over the past year, against $2M the year before.
IMCC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +22% | +35.5K shares |
| 1 year | +166% | +123K shares |
| 3 years | +680% | +172K shares |
IMCC has 197,633 diluted shares, up 166% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
IMCC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 14.0x | High |
| Q4 2023 | 26.3x | High |
IMCC's net debt is about 14 years of its operating earnings (EBITDA).
IMCC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.7 | Oversold |
| Stochastic | 0.6 | Oversold |
IMCC's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).
IMCC PE vs Healthcare Sector
IMCC has no meaningful PE right now: it lost money over the past year.
IMCC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.34 | 59% below |
| 20 week MA | $2.68 | 79% below |
| 50 week MA | $15.3 | 96% below |
| 100 week MA | $40.2 | 99% below |
| 200 week MA | $75.3 | 99% below |
IMCC is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
IMCC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3,556.8 | $15,120.0 | +325% |
| 2021 | $15,120.0 | $6,516.0 | -57% |
| 2022 | $6,516.0 | $189.0 | -97% |
| 2023 | $189.0 | $64.2 | -66% |
| 2024 | $64.2 | $73.2 | +14% |
| 2025 | $73.2 | $42.9 | -41% |
| 2026 YTD | $42.9 | $0.55 | -99% |
IMCC's yearly returns have swung widely, from +325% in 2020 to −97% in 2022. It's down 99% so far in 2026.